Riskpilot← Back to searchSign inGet full accessNEW WORLD CONSULTING AS
ASActiveOrg 983089720Svingen 10A, 0196 OsloBusiness and other management consultancy activities · NACE 7020Est. 20010 employees
Revenue 2025
NOK 0
EBITDA margin
—
+11% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
NOK -863K
-411% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -65K | +11% |
| Net profit | NOK -863K | -411% |
| Total assets | NOK 6M | -13% |
| Equity | NOK 6M | -13% |
| Employees | 0 | — |
Legal name
NEW WORLD CONSULTING AS
Org number
983089720
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
12. mars 2001
Share capital
NOK 70 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Rådgivning og konsulentvirksomhet med dertil tilhørende virksomhet. Videre investering i aksjer, verdipapir og fast eiendom.
Address
Svingen 10A, 0196 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −9 | −0 | −0 | −0 | −0 |
| EBITDA | −205 | −31 | −55 | −73 | −65 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −205 | −31 | −55 | −73 | −65 |
| Net financials | 3 050 | 2 | −223 | −96 | −798 |
| Profit before tax | 2 846 | −29 | −278 | −169 | −863 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 2 846 | −29 | −278 | −169 | −863 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 21 960 | 8 377 | 7 066 | 6 897 | 6 035 |
| Equity | 21 957 | 7 844 | 7 066 | 6 897 | 6 035 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 | 532 | 0 | 0 | 0 |
| Total debt | 2 | 532 | 0 | 0 | 0 |
EBITDA margin
-6500000.0%
This company
15.8%
Market median
-41139341% vs market
20212025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212025
Return on equity
-14.3%
This company
18.4%
Market median
-178% vs market
20212025
Net profit margin
-86252500.0%
This company
8.1%
Market median
-1064845779% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (2) | ||
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2020 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NEW WORLD CONSULTING AS 
DRUGLIMO INVEST ASBoard members of NEW WORLD CONSULTING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jann Ove Druglimo | Chairman | 0 companies |
| Eva Druglimo | Board of Directors | 0 companies |
| Randi Beate Druglimo | Board of Directors | 0 companies |
| Katerina Marita Mavromatis | Board of Directors | 0 companies |